Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies

DiscussionPopulation-based evidence for other SGAs and metabolic outcomes was limited. However, clozapine and olanzapine were consistently more strongly associated with metabolic adverse events than were other SGAs currently available.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research